Media Releases

EMERGING TRENDS IN PROBIOTICS MARKET

Posted on 12 October 2016 by KenResearch Healthcare ,

Bacteria are another name for a disease in a layman language and we often happen to misunderstand the work and impact of bacteria to our body. As wisely said “There are always two sides of a coin”, similarly there are sides of bacteria, where bad bacteria turn into a disease and good bacteria help in digestion for our body. Another name for good bacteria is Probiotics, which are microorganisms, such as live bacteria and yeasts helping our body to keep the good health.

Probiotic products aid in treating neurological disorders and many digestive problems. They have as well many applications to diagnose mental illness, strengthening theimmune system, protection from oxidative destruction to proteins and lipids. Probiotics are naturally available in our bodies and as well can be found in some foods and supplements.

According to Ken Research The report titled “WORLD PROBIOTICS MARKET-OPPORTUNITIES AND FORECASTS, 2014-2022” offers thorough analysis of the opportunities, emerging trends and forecasts till 2022 of the Probiotic market. The report cover Porter Five Forces Model, Value chain Analysis , Market Segmentation by By Ingredient, Bacteria, Yeast, by function, Preventive Healthcare, Therapeutic, By Application, Dietary Supplements, Food & Beverage, By End Use, Animal Feed, Human Probiotics, Animal Probiotics. Report also discuss major geographies in detail.

The Probiotic market is not very old; people started to pay interest in knowing more about probiotics health benefits since mid-1990s. And because of its newly discovered fame, we can find them in many products like chocolates, yogurt and are sold as tablets, capsules, gel and powders.A huge increase in probiotic products demand is witnessed in past few years and many factors contribute to the growing awareness of this market. Consumer inclination towards natural products, rising consumer concerns on preventive healthcare have propelled the growth of probiotics. The innovativenessin the products offered in market in the form of beverages, functional foods and dietary supplements is amusing the global population. Probiotic demand is at upswing worldwide. A study confirms that in US 19% of respondents claim to consume probiotics in one form or the other due to digestive concerns and reportedly, 7% of these consumers do not even have digestive issues.

Improved living standards and increasing disposable incomes in developing countries supplement the growth of the market.In addition, chronic diseases like diarrhoea and bowel diseases have been the major driving factors for probiotic medicines in the market.

On the contrary, paramount factors restricting the growing market are observed to be:

1.   Lack in microorganism concentrationstandardization in probiotic products.

2.  Sky-scraping prices of ingredients.

3.  Lacking awareness about benefits of probiotics.

Support of proactive government on seeking approval from Food & Drug Administration regarding probiotic foods and supplements is expected to be a lucrative opportunity for the growing market. Another driving factor which is growing awareness among globe is International conferences, publications on probiotics and several functional food fact sheets.

There ismuch segmentation on which the probiotics market is based which includes:

1.   Ingredient

2.   Application

3.   Function

4.    End use

5    Geography

The market segmentationon the basis of ingredient is categorised as bacteria and yeast. In powered or liquid form probiotic bacteria are induced with Probiotic foods like Yogurt. Similarly for therapeutic purposesYeast probiotics are said to be used. In the year of 2014 bacteria share was accounted for the maximum revenue and owing to the health benefits it provides, its position is anticipated to be consolidated during the forecast period.

Similarly, the market segmentation on the basis of application is categorised as food and beverages, animal feed and dietary supplements. The most liked mode of consuming probiotics is Food & beverages and its dominance is expected to be maintained during its forecast period. On the other hand due to increase in demand for botanical and natural health supplements, the dietary supplements market is expected to be growing fast.

The market segmentation on the basis of function is divided into regular,therapeutic and preventive healthcare. Due to increase in applications in pharmaceutical industry, preventive healthcare function amongst all is calculated to grow with a highest growth rate.  By user end, probiotics market segmentation is categorised into animal and human probiotics. Where in 2014Human probiotics market has dominated over the overall market and throughout the forecast period it is expected to generate highest revenue.

The four regions on the basis of which the market is analysed are Europe, North America,Asia-Pacific and LAMEA. During the forecast period Asia-Pacific is expected to continue as the highest revenue-generating region. The major players which are operating in market areBioGaia AB, Chr. Hansen Holding A/S,Danone, Yakult Honsha Co., Lifeway Foods, Nestle S.A., E. I. du Pont de Nemours and Company,GanedenInc and Protexin.

Geographies Covered:

North America

U.S.

Mexico

Canada

Europe

UK

Germany

France

Italy

Rest of Europe (The Netherlands, Spain, Turkey and others)

Asia-Pacific

China

India

 

 Topics Coverd in The Teport 

Global Nutraceuticals Market Size

World Probiotics Industry Research

Global Yeast Market Research

Dietary Supplements Market Research 

Global Animal Feed market Size

Food and Beverages Market Research 

US probiotics Market research

Germany Probiotics Consumption

Italy probiotics market Size

Probiotics Consumption China

To know more on the coverage, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/world-probiotics-market-opportunities/48763-91.html 

Related Reports:

Surface Protein gp120-Pipeline Review, H2 2016
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL)-Pipeline Review, H2 2016

 

...

Read more…